• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服吸附剂对实验性尿毒症大鼠血清中对甲酚蓄积的抑制作用。

Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats.

作者信息

Niwa T, Ise M, Miyazaki T, Meada K

机构信息

Department of Internal Medicine, Nagoya University Branch Hospital, Japan.

出版信息

Nephron. 1993;65(1):82-7. doi: 10.1159/000187446.

DOI:10.1159/000187446
PMID:8413797
Abstract

Serum p-cresol and phenol are markedly accumulated in uremic patients. To determine if an oral sorbent (AST-120) can decrease their serum concentrations in the uremic state, an oral sorbent was administered to experimental nephrectomized uremic rats. In uremic rats fed with oral sorbent, the serum concentration and the urinary excretion of p-cresol were markedly and significantly lower than those in control uremic rats, while those of phenol tended to be low in the uremic rats with oral sorbent as compared with control uremic rats. The concentrations of serum creatinine and blood urea nitrogen were significantly decreased in the uremic rats with oral sorbent. These findings demonstrate that oral sorbent adsorbs especially p-cresol in the intestine and prevents the accumulation of p-cresol in the serum of uremic rats.

摘要

血清对甲酚和苯酚在尿毒症患者体内显著蓄积。为了确定口服吸附剂(AST - 120)是否能降低尿毒症状态下它们的血清浓度,将口服吸附剂给予实验性肾切除的尿毒症大鼠。在喂食口服吸附剂的尿毒症大鼠中,对甲酚的血清浓度和尿排泄量明显且显著低于对照尿毒症大鼠,而与对照尿毒症大鼠相比,口服吸附剂的尿毒症大鼠中苯酚的血清浓度和尿排泄量则趋于降低。口服吸附剂的尿毒症大鼠血清肌酐和血尿素氮浓度显著降低。这些发现表明,口服吸附剂在肠道中尤其吸附对甲酚,并防止对甲酚在尿毒症大鼠血清中蓄积。

相似文献

1
Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats.口服吸附剂对实验性尿毒症大鼠血清中对甲酚蓄积的抑制作用。
Nephron. 1993;65(1):82-7. doi: 10.1159/000187446.
2
[Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].[口服吸附剂AST-120对尿毒症大鼠血清硫酸吲哚酚浓度的影响]
Nihon Jinzo Gakkai Shi. 1990 Jun;32(6):695-701.
3
Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats.口服吸附剂对实验性尿毒症大鼠血清中白蛋白结合硫酸吲哚酚蓄积的抑制作用。
Nephron. 1991;57(1):84-8. doi: 10.1159/000186222.
4
Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection.通过高效液相色谱-荧光检测法测定,苯酚和对甲酚在尿毒症血清中蓄积。
Clin Chem. 1993 Jan;39(1):108-11.
5
Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats.口服吸附剂可降低实验性尿毒症大鼠血清和尿液中硫酸吲哚酚的水平。
Am J Nephrol. 1992;12(4):201-6. doi: 10.1159/000168447.
6
Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.应用液相色谱/串联质谱法对口服吸附剂 AST-120 的作用进行代谢组学搜索,以寻找尿毒症毒素作为其作用的指标。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 1;878(29):2997-3002. doi: 10.1016/j.jchromb.2010.09.006. Epub 2010 Sep 15.
7
An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats.口服吸附剂AST-120可抑制尿毒症大鼠的氧化应激。
Am J Nephrol. 2006;26(5):455-61. doi: 10.1159/000096423. Epub 2006 Oct 18.
8
Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.硫酸吲哚酚与肾衰竭进展:低蛋白饮食和口服吸附剂对尿毒症大鼠及未透析尿毒症患者硫酸吲哚酚生成的影响
Miner Electrolyte Metab. 1997;23(3-6):179-84.
9
Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.硫酸吲哚酚是一种循环性尿毒症毒素,可促进肾小球硬化的进展。
J Lab Clin Med. 1994 Jul;124(1):96-104.
10
Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.对接受血液透析的尿毒症患者口服乳酸菌制剂Lebenin后,其血液中尿毒症毒素及其粪便中前体物质的蓄积的抑制作用。
Nephron. 1996;74(2):349-55. doi: 10.1159/000189334.

引用本文的文献

1
A Historical Perspective on Uremia and Uremic Toxins.对尿毒症和尿毒症毒素的历史透视。
Toxins (Basel). 2024 May 15;16(5):227. doi: 10.3390/toxins16050227.
2
Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.采用 LC-ESI-MS/MS 技术评估维持性血液透析的晚期慢性肾脏病患者的尿毒症毒素。
Metabolomics. 2023 Feb 24;19(3):14. doi: 10.1007/s11306-023-01978-z.
3
The Evolving View of Uremic Toxicity.尿毒症毒性的演变观点。
Toxins (Basel). 2022 Apr 12;14(4):274. doi: 10.3390/toxins14040274.
4
Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.尿毒症毒素在肾脏、心血管和骨骼功能障碍中的作用。
Toxins (Basel). 2018 May 16;10(5):202. doi: 10.3390/toxins10050202.
5
Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.司维拉姆对非透析慢性肾脏病患者血浆对甲酚的降低作用:一项随机对照试验的证据
Clin Exp Nephrol. 2018 Jun;22(3):529-538. doi: 10.1007/s10157-017-1504-8. Epub 2017 Nov 20.
6
p-Cresyl Sulfate.对甲酚硫酸盐
Toxins (Basel). 2017 Jan 29;9(2):52. doi: 10.3390/toxins9020052.
7
The gut-kidney axis.肠-肾轴。
Pediatr Nephrol. 2017 Nov;32(11):2005-2014. doi: 10.1007/s00467-016-3527-x. Epub 2016 Nov 15.
8
Plasma p-cresol lowering effect of sevelamer in peritoneal dialysis patients: evidence from a Cross-Sectional Observational Study.在腹膜透析患者中,司维拉姆降低血浆对甲酚的效果:来自横断面观察研究的证据。
PLoS One. 2013 Aug 28;8(8):e73558. doi: 10.1371/journal.pone.0073558. eCollection 2013.
9
Bisphenol a in chronic kidney disease.慢性肾病中的双酚A
Int J Nephrol. 2013;2013:437857. doi: 10.1155/2013/437857. Epub 2013 Jul 31.
10
An update on uremic toxins.尿毒症毒素的最新研究进展。
Int Urol Nephrol. 2013 Feb;45(1):139-50. doi: 10.1007/s11255-012-0258-1. Epub 2012 Aug 15.